These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 964279)

  • 41. [The electrophysiological effects of disopyramide (author's transl)].
    Ponsonnaille J; Marcheix JC; Gras H
    Ann Cardiol Angeiol (Paris); 1977; 26(2):135-9. PubMed ID: 900834
    [No Abstract]   [Full Text] [Related]  

  • 42. [Electrophysiological interrelations of disopyramide with atropine].
    González Maqueda I; García Fernández F; Martin Jadraque L; López Sendon JL; Coma Canella I
    Rev Esp Cardiol; 1979; 32(2):127-31. PubMed ID: 472418
    [No Abstract]   [Full Text] [Related]  

  • 43. [Hemodynamic effects of disopyramide and procainamide in open-chest animals].
    Binetti G; Branzi A; Malini PL; Specchia S; Magelli C; Zannoli R; Magnani B
    G Ital Cardiol; 1978; 8(12):1314-9. PubMed ID: 738572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Electrophysiological effects of nifedipine in humans. Preliminary note].
    Disertori M; Molinis G; Antonini L; Furlanello F
    Minerva Cardioangiol; 1978 Nov; 26(11):713-9. PubMed ID: 724117
    [No Abstract]   [Full Text] [Related]  

  • 45. Effects of disopyramide on electrophysiological and mechanical properties of the heart.
    Yeh BK; Sung PK; Scherlag BJ
    J Pharm Sci; 1973 Dec; 62(12):1924-9. PubMed ID: 4762159
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of disopyramide and disobutamide on conduction in perfused rabbit hearts.
    Dresel PE; Cameron KD
    Can J Physiol Pharmacol; 1981 Nov; 59(11):1192-5. PubMed ID: 7317843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of disopyramide on repolarisation and intraventricular conduction in man.
    Endresen K; Amlie JP; Forfang K
    Eur J Clin Pharmacol; 1988; 35(5):467-74. PubMed ID: 2466670
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cardiac effects of disopyramide.
    Danilo P; Rosen MR
    Am Heart J; 1976 Oct; 92(4):532-6. PubMed ID: 785992
    [No Abstract]   [Full Text] [Related]  

  • 49. Clinical and electrophysiological observations with disopyramide in drug-resistant and recurrent symptomatic arrhythmias.
    Myers JB; Millar RN; Obel IW
    S Afr Med J; 1978 Dec; 54(26):1083-9. PubMed ID: 746466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemodynamic effects of intravenous disopyramide in heart failure.
    Jensen G; Sigurd B; Uhrenholt A
    Eur J Clin Pharmacol; 1975 Apr; 8(3-4):167-73. PubMed ID: 1233215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Electrophysiological effects of disopyramide and quinidine on guinea pig atria and canine cardiac purkinje fibers. Dependence on underlying cholinergic tone.
    Mirro MJ; Watanabe AM; Bailey JC
    Circ Res; 1980 May; 46(5):660-8. PubMed ID: 7363415
    [No Abstract]   [Full Text] [Related]  

  • 52. Electrophysiological effects of disopyramide phosphate during experimental myocardial ischemia.
    Levites R; Anderson GJ
    Am Heart J; 1979 Sep; 98(3):339-44. PubMed ID: 474380
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Electrophysiological effects of a new antiarrhythmic agent, lorcainide, on the isolated cardiac muscle fiber as compared with disopyramide.
    Shigenobu K; Atoda H; Asano T; Kasuya Y
    J Pharmacobiodyn; 1980 Dec; 3(12):677-85. PubMed ID: 7277183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Electrophysiological evaluation of disopyramide in man.
    Josephson ME; Caracta AR; Lau SH; Gallagher JJ; Damato AN
    Am Heart J; 1973 Dec; 86(6):771-80. PubMed ID: 4757788
    [No Abstract]   [Full Text] [Related]  

  • 55. Cardiac depression by intravenous disopyramide in patients with left ventricular dysfunction.
    Leach AJ; Brown JE; Armstrong PW
    Am J Med; 1980 Jun; 68(6):839-44. PubMed ID: 7386491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of combined administration of verapamil and disopyramide in dogs.
    Lee JT; Davy JM; Kates RE
    J Cardiovasc Pharmacol; 1985; 7(3):501-7. PubMed ID: 2410681
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological effects of disopyramide phosphate in patients with sinus node dysfunction.
    Tsuchioka Y; Mitsuda H; Eno S; Fujitani K; Furuta Y; Yoshida M; Miyoshi A; Tateishi H; Satou H
    Jpn Circ J; 1982 Jul; 46(7):693-700. PubMed ID: 6808188
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
    Lara M; Oakley GD; Rowbotham D
    Br Med J; 1980 Jul; 281(6234):198. PubMed ID: 7407521
    [No Abstract]   [Full Text] [Related]  

  • 59. Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine.
    Kötter V; Linderer T; Schröder R
    Am J Cardiol; 1980 Sep; 46(3):469-75. PubMed ID: 7415992
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemodynamic and electrocardiographic effects of intravenous disopyramide (rythmodan) following acute myocardial infarction.
    Davies GJ; Marrott PK; Muir JR
    Br J Clin Pharmacol; 1979 Feb; 7(2):183-7. PubMed ID: 760751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.